Cardiology Research Institute, Tomsk National Research Medical Center of the RAS, 634012 Tomsk, Russia.
Cells. 2023 Jun 14;12(12):1622. doi: 10.3390/cells12121622.
Acute myocardial infarction (AMI) remains the leading cause of mortality in the world, highlighting an urgent need for the development of novel, more effective approaches for the treatment of AMI. Remote postconditioning (RPost) of the heart could be a useful approach. It was demonstrated that RPost triggers infarct size reduction, improves contractile function of the heart in reperfusion, mitigates apoptosis, and stimulates autophagy in animals with coronary artery occlusion and reperfusion. Endogenous opioid peptides and adenosine could be involved in RPost. It was found that kinases and NO-synthase participate in RPost. KATP channels, MPT pore, and STAT3 could be hypothetical end-effectors of RPost. Metabolic syndrome and old age abolish the cardioprotective effect of RPost in rats. The data on the efficacy of RPost in clinical practice are inconsistent. These data are discussed in the review.
急性心肌梗死(AMI)仍然是世界上导致死亡的主要原因,这凸显了迫切需要开发新的、更有效的 AMI 治疗方法。心脏远程后处理(RPost)可能是一种有用的方法。已经证明,RPost 可触发梗死面积缩小,改善冠状动脉闭塞和再灌注动物的心脏再灌注时的收缩功能,减轻细胞凋亡,并刺激自噬。内源性阿片肽和腺苷可能参与 RPost。已经发现激酶和 NO 合酶参与 RPost。KATP 通道、MPT 孔和 STAT3 可能是 RPost 的假设终效器。代谢综合征和老年使 RPost 在大鼠中的心脏保护作用失效。关于 RPost 在临床实践中的疗效的数据不一致。本文对这些数据进行了讨论。